Skip to content
AnthologyRX

NAD+ and aging: what we actually know

Energy. Recovery. Staying sharp. NAD+ sits at the center of the conversation because it plays a real role in cellular metabolism. Understanding the research helps you separate that biology from the results a treatment can deliver.

What NAD+ does inside a cell

NAD+, short for nicotinamide adenine dinucleotide, participates in the reactions cells use to process energy. Its reduced form, NADH, carries electrons through metabolism. NAD+ also supports enzyme systems involved in cellular signaling and repair. This makes it a meaningful research target, but a molecule's role inside a cell is only the starting point for evaluating treatment. Human NAD+ research.

Does NAD+ decline with age?

Some human measurements show an association. A 2015 brain-imaging study found lower NAD+ and altered NAD+/NADH balance with increasing age in healthy volunteers. That was a study of the brain, using a particular measurement method. It does not establish that every adult loses half their NAD+ by midlife, or that the same pattern occurs throughout the body. Read the study.

Age alone cannot tell you whether NAD+ treatment will improve your energy. Persistent fatigue or changes in concentration deserve a broader assessment, including sleep, medications and other possible causes.

Raising a measurement and improving an outcome are different questions

A randomized crossover trial in middle-aged and older adults found that oral nicotinamide riboside increased NAD+-related measures. Nicotinamide riboside is a precursor the body can use to make NAD+. It is a different molecule and delivery approach from an NAD+ injection. The trial does not establish that either approach extends human lifespan. Read the oral NR trial.

A small 2019 pilot followed blood and urine metabolites during a six-hour NAD+ infusion. It helped characterize what happens to NAD+ during IV administration. It did not test whether the treatment improves day-to-day energy, training recovery or longevity, and it did not evaluate subcutaneous injections. Read the infusion study.

What to compare before choosing a format

Start with the actual ingredient, delivery route and outcome being studied. An oral precursor study cannot stand in for an injection trial. An IV study cannot automatically validate a nasal spray. A more direct route also does not, by itself, establish a better clinical result.

Our NAD+ format comparison brings those differences together. The injection plan details explain the available format, package and billing, so you can consider the practical commitment alongside the research.

Where prescription care fits

AnthologyRX offers compounded NAD+ through a clinical assessment. Your medical history, current medications and reasons for seeking care inform the prescribing decision. Compounded medications are not FDA-approved products; their safety, effectiveness and quality are not reviewed by FDA before marketing in the same way as approved drugs. FDA's explanation of compounding.

NAD+ offers an interesting window into energy metabolism and aging. The useful question is specific: what evidence supports this formulation for the outcome you want?

Sources

  1. Zhu et al. NAD contents and redox state in the human brain

    PNAS, 2015. Human magnetic-resonance measurements and age associations.

  2. Martens et al. Nicotinamide riboside in middle-aged and older adults

    Nature Communications, 2018. Oral NR, a different molecule from NAD+.

  3. Grant et al. NAD+ metabolism during a six-hour IV infusion

    Frontiers in Aging Neuroscience, 2019. Small human metabolite pilot, not an energy or recovery efficacy trial.

  4. FDA: Compounding questions and answers

    The distinction between compounded medications and FDA-approved drug products.

AnthologyRX
Find your treatment
Browse all treatments